Nachrichten zur QuidelOrtho Corp Aktie

QDEL Stock Down as Q1 Earnings Miss Estimates, Revenues Down Y/Y

QuidelOrtho posts a wider Q1 loss as revenues fell 10.5% year over year, with weakness in respiratory testing pressuring margins…

QuidelOrtho (QDEL) Reports Q1 Loss, Tops Revenue Estimates

QuidelOrtho (QDEL) delivered earnings and revenue surprises of -110.81% and +0.28%, respectively, for the quarter ended March 2026. Do the…

QuidelOrtho Looks Mispriced If 2026s FCF Turnaround Materializes

…

QuidelOrtho stock plunges on weak revenue guidance

QuidelOrtho stock plunges on weak revenue guidance…

QuidelOrtho Corp Director Purchases 10k Shares as CFO Retires

QuidelOrtho Corporations stock has been falling for multiple years, but after a board member purchased shares, could the stock soon…

QuidelOrtho Q4 Earnings and Revenues Beat Estimates, Margins Down

QDEL beats Q4 estimates as Labs and global growth lift sales, but shrinking margins and respiratory weakness weigh on profits.…

QuidelOrtho (QDEL) Q4 Earnings and Revenues Top Estimates

QuidelOrtho (QDEL) delivered earnings and revenue surprises of +7.80% and +3.62%, respectively, for the quarter ended December 2025. Do the…

QuidelOrtho Q3 Earnings and Revenues Beat Estimates, Margins Expand

QDEL tops Q3 estimates as Labs and Immunohematology units drive growth, while margins strengthen despite respiratory revenue declines.…

QuidelOrtho (QDEL) Down 18% Since Last Earnings Report: Can It Rebound?

QuidelOrtho (QDEL) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates for…

QuidelOrtho explodiert: 40?% Plus nach Zahlenvorlage

QuidelOrtho Corporation ist ein weltweit führendes Unternehmen im Bereich der In-vitro-Diagnostik mit Hauptsitz in den USA. Entstanden aus der Fusion…

QuidelOrtho (QDEL) Q1 Earnings and Revenues Top Estimates

QuidelOrtho (QDEL) delivered earnings and revenue surprises of 27.59% and 0.30%, respectively, for the quarter ended March 2025. Do the…

QuidelOrtho (QDEL) Earnings Expected to Grow: Should You Buy?

QuidelOrtho (QDEL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.…

QuidelOrtho (QDEL) Surges 10.1%: Is This an Indication of Further Gains?

QuidelOrtho (QDEL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might…

QuidelOrtho Unveils Results Manager System to Streamline Testing

QDEL introduces the Results Manager System, a powerful tool designed to streamline diagnostic data management, enhance efficiency, and improve patient…

QuidelOrtho: Growth Struggles And Negative GAAP Earnings Continue To Disinterest Investors

…

$30+ Bn Primary Care POC Diagnostics Market Opportunities and Strategies to 2033: F. Hoffmann-La Roche Leads with 10.51% Share, Followed by Siemens Healthineers and QuidelOrtho

Dublin, Feb. 19, 2025 (GLOBE NEWSWIRE) -- The "Primary Care POC Diagnostics Market Opportunities and Strategies to 2033"…

Why QuidelOrtho Stock Bounced More Than 4% Higher Today

Healthcare in vitro diagnostics company QuidelOrtho (NASDAQ: QDEL) attracted the right kind of attention from investors after posting its latest…

QuidelOrtho (QDEL) Q4 Earnings and Revenues Top Estimates

QuidelOrtho (QDEL) delivered earnings and revenue surprises of 14.55% and 0.79%, respectively, for the quarter ended December 2024. Do the…

QuidelOrtho expands board with healthcare veterans By Investing.com

QuidelOrtho expands board with healthcare veterans…

QuidelOrtho: Highly Levered With Questionable Growth

…

QUIDELORTHO ALERT: Bragar Eagel & Squire, P.C. is Investigating QuidelOrtho Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

QuidelOrtho (QDEL) Q2 Earnings Beat Estimates, U.S. Sales Down

QuidelOrthos (QDEL) second-quarter results reflect growth in revenues. However, gross profit continues to decline.…

Carlyle group entities sell over $4.8 million in QuidelOrtho stock By Investing.com

Carlyle group entities sell over $4.8 million in QuidelOrtho stock…

QUIDELORTHO ALERT: Bragar Eagel & Squire, P.C. is Investigating QuidelOrtho Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ocugen, Sonder, QuidelOrtho, and Perion Innovations and Encourages Investors to Contact the Firm

NEW YORK, June 07, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ocugen, Sonder, QuidelOrtho, and Perion Innovations and Encourages Investors to Contact the Firm

NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

QDEL INVESTOR ALERT: Kirby McInerney LLP Alerts QuidelOrtho Corporation Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit

NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of…

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against QuidelOrtho Corporation – QDEL

NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been…

QuidelOrtho (QDEL) Class Action Filed After QDEL Reports Disastrous Q4 2023 Results, Terminates CEO, Withdraws FDA Submission - Hagens Berman

HAGENS BERMAN Encourages QDEL Investors Who Suffered Substantial Losses to Contact Firm HAGENS BERMAN Encourages QDEL Investors Who Suffered Substantial…

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of QuidelOrtho

NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm,…

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against QuidelOrtho Corporation – QDEL

NEW YORK, May 20, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against QuidelOrtho, Perion, Doximity, and SpaceMobile and Encourages Investors to Contact the Firm

NEW YORK, May 16, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

QuidelOrtho gains as activist Jana shows new share stake By Investing.com

QuidelOrtho gains as activist Jana shows new share stake…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against QuidelOrtho, Perion, Doximity, and Sharecare and Encourages Investors to Contact the Firm

NEW YORK, May 12, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against QuidelOrtho Corporation – QDEL

NEW YORK, May 12, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been…

QuidelOrtho (QDEL) Q1 Earnings Beat Estimates, Margins Fall

QuidelOrthos (QDEL) first-quarter results reflect growth in revenues, excluding the COVID-19 revenue impact.…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against QuidelOrtho, Perion, Doximity, and Sharecare and Encourages Investors to Contact the Firm

NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ocugen, QuidelOrtho, Sharecare, and GoodRx and Encourages Investors to Contact the Firm

NEW YORK, May 02, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against QuidelOrtho Corporation (QDEL)

LOS ANGELES, April 30, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ocugen, QuidelOrtho, Sharecare, and GoodRx and Encourages Investors to Contact the Firm

NEW YORK, April 28, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

Dicello Levitt LLP Announces Investor Class Action Lawsuit Filed Against QuidelOrtho Corp. f/k/a Quidel Corp. (NASDAQ: QDEL) And Lead Plaintiff Deadline

QuidelOrtho Corp. (NASDAQ: $QDEL) Investor Alert: Investors Encouraged to Retain Counsel Before Important Class Action Deadline.…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ocugen, QuidelOrtho, and Sharecare and Encourages Investors to Contact the Firm

NEW YORK, April 23, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

QDEL INVESTOR ALERT: Securities Fraud Class Action Filed After QuidelOrtho (QDEL) Reports Disastrous Q4 2023 Results, Terminates CEO, Withdraws FDA Submission - Hagens Berman

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages QDEL Investors Who Suffered Substantial Losses to Contact its Attorneys HAGENS BERMAN, NATIONAL TRIAL…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ocugen, and QuidelOrtho and Encourages Investors to Contact the Firm

NEW YORK, April 19, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

QDEL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that QuidelOrtho Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally…

QUIDELORTHO ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against QuidelOrtho Corporation and Encourages Investors to Contact the Firm

NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights…

QuidelOrtho: Attractive Valuation Despite Weak Performance

…

QuidelOrtho (QDEL) Securities Fraud Class Action Filed After QDEL Reports Disastrous Q4 2023 Results, Terminates CEO, Withdraws FDA Submission - Hagens Berman

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages QDEL Investors Who Suffered Substantial Losses to Contact its Attorneys HAGENS BERMAN, NATIONAL TRIAL…

ROSEN, A TOP RANKED LAW FIRM, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation – QDEL

NEW YORK, April 12, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…

QuidelOrthos (QDEL) New Test to Offer Enhanced Opioid Testing

QuidelOrthos (QDEL) addition of the Fentanyl Test is likely to deliver rapid drugs-of-abuse detection amidst the escalating opioid crisis.…